HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R41/R42 Clinical Trial Not Allowed) | | RFA-NS-23-007 | Department of Health and Human Services National Institutes of Health | 4/4/25 | 9/15/22 |
Revision Applications for Regenerative Medicine Innovation Projects (RMIP) (P41) | | RFA-HL-17-033 | Department of Health and Human Services National Institutes of Health | 6/26/17 | 4/28/17 |
Multidisciplinary Approaches to HIV-Associated Comorbidities and Prioritizing Intervention Targets (R01 Clinical Trial Not Allowed) | | PAR-21-027 | Department of Health and Human Services National Institutes of Health | 1/7/23 | 9/30/20 |
PHS 2019-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed | | PA-19-272 | Department of Health and Human Services National Institutes of Health | 7/6/20 | 5/7/19 |
HEAL Initiative: Sickle Cell Disease Pain Management Trials Utilizing the Pain Management Effectiveness Research Network Cooperative Agreement (UG3/UH3, Clinical Trial Required) | | RFA-AT-22-005 | Department of Health and Human Services National Institutes of Health | 12/15/21 | 10/29/21 |